dRx Capital
Wagniskapital- und Private-Equity-Auftraggeber
Novartis Digital Health Venture Capital
Info
dRx Capital backs exceptional entrepreneurs transforming healthcare through data and digital technology. The fund, backed by Novartis, invests in technology platforms improving access to healthcare and reimagining the practice of medicine, with a focus on AI & ML, big data, R&D optimization, patient care, and pharma supply chain and commercialization. dRx Capital currently has 20 portfolio companies, including: Aktana, Animantis, Aspen RxHealth, Cala Health, Cota Health, Flywheel, Freenome, H1, Koneksa, Mekonos, NuvoAir, Omada, Pear Therapeutics, Peptone, RxVantage, SchoolCare, Science 37, SomaLogic, Vineti, Xealth.
- Website
-
https://drxcapital.com/
Externer Link zu dRx Capital
- Branche
- Wagniskapital- und Private-Equity-Auftraggeber
- Größe
- 2–10 Beschäftigte
- Hauptsitz
- Basel
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
Orte
-
Primär
CH-4056
Basel, CH
-
44 Montgomery St
San Francisco, California 94104, US
-
181 Massachusetts Ave
Cambridge, Massachusetts 02139, US